T-cell receptor gamma chain (TCRG)

The T-cell receptor gamma chain (TCRG) is a protein subunit that, along with the delta chain, forms the gamma-delta (γδ) T-cell receptor (TCR) complex found on a specialized subset of T cells (UniProt: P01850). Unlike alpha-beta T cells, γδ T cells recognize antigens directly without the requirement for Major Histocompatibility Complex (MHC) presentation, allowing for rapid immune responses to stressed, infected, or transformed cells (PubMed: 30111630). The TCR gamma chain is encoded by the TRG locus, and its genetic rearrangement is a hallmark of T-cell development and a key diagnostic biomarker for T-cell malignancies (NCBI Gene: 6965). In therapeutic contexts, the TCR gamma chain is a target for novel immunotherapies, including CAR-T cells and bispecific T-cell engagers, which aim to harness the innate-like cytotoxic potential of γδ T cells (PubMed: 31913340). These therapies are particularly attractive in oncology due to their low risk of inducing graft-versus-host disease (GvHD) compared to traditional alpha-beta T-cell products. Current research also explores the role of TCRG in autoimmune diseases and chronic infections, where γδ T-cell dysregulation contributes to pathology.

Other names

TRGT-cell receptor gamma locusTCR gammaT-cell antigen receptor gamma subunitT-cell receptor gamma constant

Drugs targeting the TCR gamma chain typically function by either activating gamma-delta T cells to enhance anti-tumor immunity or by utilizing the chain as a specific marker for CAR-T cell engineering to target malignancies while minimizing graft-versus-host disease (PubMed: 31913340). MHC-independent activation allows these therapies to target cells that have downregulated MHC class I to evade the immune system.